Bladder Cancer Home Test
Prescription home test that aids in Bladder Cancer diagnosis and monitoring
What is the Alere NMP22® BladderChek® Test?
Prescribed by a doctor, the Alere NMP22® BladderChek® Test is the only FDA cleared prescription home test that aids in the diagnosis and monitoring of bladder cancer for symptomatic, at risk, and monitoring patients. The test is clinically proven, patient friendly, and cost effective. More frequent testing at home can give you peace of mind and lead to early detection.
How often should I test at home with the Alere NMP22® BladderChek® Test?
As often as you want. More frequent testing can give you peace of mind and lead to earlier detection. However, discuss home testing with your doctor to determine the best frequency for you. Always remember to attend your regularly scheduled doctor appointments while continuing your home testing schedule with Alere NMP22® BladderChek® Test and consult your doctor with all questions regarding test results.
